Proteon reports positive data from Phase II trial of PRT-201
Proteon Therapeutics has reported positive Phase II trial results of PRT-201 in chronic kidney disease (CKD) patients undergoing surgical placement of an arteriovenous fistula for hemodialysis.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Chronic Kidney Disease | Dialysis | Hemodialysis | Pharmaceuticals | Urology & Nephrology